Skip to content
Just-Evotec Biologics
Just-Evotec BiologicsJust-Evotec Biologics
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
      • Interviews
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec
Search:
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
      • Interviews
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec

News & Insights

View allAd hocDDup 11InterviewsPostersPress ReleasePublicationsScientific journalsTechnological insightsTrade journalsWebinarsWhite Papers & Application Notes

Just – Evotec Biologics awarded contract from U.S. Department of Defense under accelerated antibodies program

Press ReleaseSeptember 20, 2022

Just–Evotec Biologics will support the DOD with rapid, cost-efficient development of safe, efficacious anti-plague mabs. Evotec will provide pre-clinical and clinical trial services.

Learn more

Evotec initiates ground-breaking for new biologics facility J.POD® Toulouse, France (EU)

Press ReleaseSeptember 19, 2022

J.POD® Toulouse, France (EU) Brings a disruptive, flexibly scalable biologics manufacturing technology to the region. The manufacturing facility is expected to be operational in H2…

Learn more

Just–Evotec Biologics and Alpine Immune Sciences expand partnership for commercial process development of ALPN-303

Press ReleaseAugust 10, 2022

Just–Evotec Biologics will apply its fully integrated technology platform to develop an optimized commercial process for ALPN-303, a dual BAFF/APRIL inhibitor for systemic lupus erythematosus…

Learn more

Evotec receives € 7.5 m grant for development of COVID-19 therapeutic

Press ReleaseJanuary 3, 2022

Under the € 7.5 m grant, Evotec will use clinical material manufactured within its Just – Evotec Biologics manufacturing platform to initiate the clinical development…

Learn more

Automated multi-attribute method sample preparation using high-throughput buffer exchange tips

Scientific journalsDecember 17, 2021

In recent years, the multi-attribute method (MAM) has become an important mass spectrometry-based tool for identifying and quantifying the site-specific product attributes and purity information…

Learn more

Development of recombinase-based targeted integration systems for production of exogenous proteins using transposon-mediated landing pads

Scientific journalsOctober 26, 2021

Current methods for stably expressing biotherapeutics in CHO cells often rely on random or semi-random integration events which result in widely heterogeneous cell populations. In…

Learn more

Evotec publishes DDup 11 – AI-driven antibody discovery at Evotec

Scientific journalsSeptember 15, 2021

The 11th edition is dedicated to our exciting new capabilities in the biologics lane of Evotec’s “Multi-modality Autobahn.” For the biologics industry, Evotec provides a…

Learn more
Introduction to antibodies

Introduction to Antibodies

DDup 11September 15, 2021

What are antibodies? Antibodies, or immunoglobulin molecules, are glycoproteins produced by the plasma B cells of the adaptive immune system with the aim to recognise…

Learn more
AI-driven antibody discovery

AI-driven antibody discovery at Evotec

DDup 11September 15, 2021

Antibody discovery may be driven by the interrogation of two primary sources: (1) in vivo (animal-derived B cells) or (2) in vitro (library-derived antibody display…

Learn more
FFmab

Function-focused antibody (FFmab) screening

DDup 11September 15, 2021

What is FFmab screening? FFmab screening is a platform for identifying novel functional antibodies that change disease-modifying phenotypes of immune cells. The platform identifies innovative…

Learn more
Karen Lackey and Jim Thomas

Interview with Dr Jim Thomas and Karen Lackey

DDup 11September 15, 2021

What role do Biologics play in the context of novel therapeutics? Jim: Biologics are a significant and growing portion of the arsenal of therapeutics used…

Learn more
Barbara Bachler-Konetzki

Interview with Barbara Bachler-Konetzki about Evotec’s integrated antibody discovery capabilities

DDup 11September 15, 2021

What were the limitations of previous hybridoma-based approaches? Although the development of the hybridoma technology was a landmark event, the methodology still faced the limitation…

Learn more
←123456→
innovation by design
North America
Just – Evotec Biologics, Inc.
401 Terry Avenue North
Seattle, WA 98109
+1 206-651-5094
Europe + International
Just – Evotec Biologics
Business Development
info@evotec.com

Find us on:

Twitter page opens in new windowLinkedin page opens in new windowMail page opens in new window
© 2023 Just – Evotec Biologics
  • Contact
  • Imprint
  • Privacy Policy
  • Legal notice
footer menu
Go to Top
  • Ask an expert
  • Tweet
  • Share
  • Email
  • Scroll to top
  • Ask an expert
  • Twitter
  • Linkedin
  • Email
  • Whatsapp